Vepalimomab
From Wikipedia, the free encyclopedia
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | VAP-1 |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 195158-85-1 |
ATC code | None |
Chemical data | |
Formula | ? |
(what is this?) (verify) | |
Vepalimomab is a mouse monoclonal antibody developed for the treatment of inflammations. It blocks the vascular adhesion protein 1.[1]
References
- ↑ Vainio, PJ; Kortekangas-Savolainen, O; Mikkola, JH; Jaakkola, K; Kalimo, K; Jalkanen, S; Veromaa, T (2005). "Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis". Basic & Clinical Pharmacology & Toxicology 96 (6): 429–35. doi:10.1111/j.1742-7843.2005.pto_05.x. PMID 15910406.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.